Sees FY24 System-wide comparable RevPAR, on a currency neutral basis up 2.0%-2.5% vs. last year. Sees FY24 Adjusted EBITDA $3.375B-$3.405B and contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties, $200M-$250M.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLT: